Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: LTK007 who wrote (519)	5/4/1998 2:21:00 PM
From: Candle stick	Respond to of 2135

Nice move in this stock today guys. Congrats to everyone who scored. Keep in mind you still have over 2 years for human clinical trials. I have a lead for anyone who is interested on a similair small biotech working on Alzheimers cure. Cortex pharmacueticals (CORX) is just 2 dollars, but was as high as 7 1/2 a little over a year ago when CNBC profiled it after its drug was proven to work on rats. Sound familiar? I am telling you this because it subsequently fell to 1 1/2 after it became apparent that they were 2 years away from conclusive clinical trials. So the lesson is don't marry ENMD yet, they still have a long way to go and you may be able to buy it substantially cheaper. In the meantime, it is now almost 2 years later for CORX and they are almost done with phase 2 human clinical trials, and will have results by mid summer. this is a pure play on Alzheimers treatment, and warrants taking a look, because if the drug has efficacy in humans we will know in just a couple of months and there will be real cash coming in much sooner than in ENMD, which will take at least 2 more years. CORX has fallen out of the limelight and is incredibly cheap, BUT, with the spotlight turning to small pureplay biotechs after Entremeds explosive pop today, I don't think CORX will be in the shadows much longer. Take a look, it can't hurt.....best of luck...........;^)

To: LTK007 who wrote (519)	5/4/1998 2:55:00 PM
From: Tom R. Clarksburg	Read Replies (2) \| Respond to of 2135

Here is some information on Shark cartilage : Active Human Trials with Clinical Quality Shark Cartilage Powder United States FDA IND #47,373 Clinical Trials: 1) Advanced non-responsive breast cancer. Underway at Hackensack University Medical Center, New Jersey. Started summer 1997. 2) Advanced non-responsive brain cancer. Underway at Hackensack University Medical Center, New Jersey. Started summer 1997. Areas of Measure: Cancer: Tumor size reduction, PSA (and other respective tumor marker levels), pain, Karnofsky Score and quality of life among at least 14 patients who have failed conventional therapy. 20 week study. Kaposi's Sarcoma: Decrease/Reversal of lesion growth or pigmentation, Karnofsky Score and quality of life of at least 20 patients. 20 week study. United Kingdom Clinical Trials : The same shark cartilage as used in FDA Trials 1) Advanced, non-responsive prostate, stomach, breast and brain cancer. Underway at Bristol Cancer Clinic. Began summer 1997. Japan: Clinical Trials : The same shark cartilage as used in FDA Trials 1) Various cancers. Shark cartilage with immune therapy. Trials underway at the Yoshita Clinic., Kyushu Japan. Here is a link to Dr lanes website: drlane.com I am not pushing shark cartilage, but I am saying that "anti-angiogenesis" is REAL and any company that develops an FDA backed drug to inhibit angiogenesis AND MOST IMPORTANTLY, be the first one, we make WINDFALL profits!!!! I know know first hand that anti-angiogenesis works because of my mother's experience with stage IV breast cancer and her remarkable recovery and remission after 2 doctors lost hope. Well the shark cartilage worked on her to the doctors' amasement!!! Now there are no more signs of her tumors after 6 years of shark cartilage therapy and no other medication. regards TOM

To: LTK007 who wrote (519)	5/4/1998 6:40:00 PM
From: Brian Malloy	Read Replies (1) \| Respond to of 2135

Max90, ref shark cartilage and hype, From Business Week in April you may be interested to learn: "Researchers have found some proteins in shark cartilage that do block blood vessel formation. Bioengineered versions include Neovastat, made by Aeterna Laboratories of Candada; squalamine from Magainin Pharmaceuticals in Plymouth Meeting, Pa.; and Troponin I, from Boston Life Sciences in Boston. All have dramatically reduced the size of tumors in mice without toxic side effects.